Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 32344
Evènement :PREDiCT: Tumor Models San Francisco 2021

Dates :Mardi 26 Janvier 2021 - Jeudi 28 Janvier 2021

Lieu :En ligne (Internet, Visioconférence, ...)

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

As the only industry-focused meeting dedicated to preclinical scientists and translational oncologists in the immunotherapy space, the PREDiCT Series is once again delighted to bring to you Tumor Models San Francisco 2021.
Running in a digital capacity this year, the 5th PREDiCT: Tumor Models San Francisco 2021 Summit enables you to discover the latest I/O preclinical strategies in the biopharmaceutical industry, evaluate and debate next-generation preclinical models for immuno-oncology studies and form high-quality connections to ensure cooperation and collaboration stays alive in a socially-distant world.
Offering a wide range of content-driven presentations, expert-led Q and A and discussion, interactive workshops, and the provision of networking opportunity, benchmark against your fellow colleagues to advance your I/O candidates towards the clinic.
https://tumor-models-sf.com/
26-28 January, 2021
8am-6pm PST | 11am-9pm EST
Contact:
info@hansonwade.com
Pricing:
Drug Developers (Earlybird rates and workshops available) - $1999
Academic (Earlybird rates and workshops available) - $1799
Model and Service Providers (Earlybird rates and workshops available) - $2499
URLs:
Prices:
Drug Developers (Earlybird rates and workshops available): USD 1999.0,
Academic (Earlybird rates and workshops available): USD 1799.0,
Model and Service Providers (Earlybird rates and workshops available): USD 2499.0
Speakers: James Keck, Senior Director - Innovation and Product Development at JMCRS, The Jackson Laboratory, Johanna Lahdenranta, Director - In Vivo Pharmacology, Bicycle Therapeutics, Maria Castro, Professor - Neurosurgery and Cell Developmental Biology, University of Michigan, Maryland Franklin, Executive Director - Scientific Development, Covance, Alwin Schuller, Senior Principal Scientist, AstraZeneca, David Langenau, Professor, Massachusetts General Hospital, Dean Campbell, Director - Scientific Engagement, CrownBio, Natalia Malkova, Senior Principal Scientist, Sanofi
Time: 08:00 - 18:00

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

PREDiCT: Tumor Models San Francisco 2021 Oncologie
--
Tout public
-- -- --
English

Recommander cet évènement